272 related articles for article (PubMed ID: 26106367)
1. Novel Insights into the Genetics and Pathophysiology of Adrenocortical Tumors.
Drougat L; Omeiri H; Lefèvre L; Ragazzon B
Front Endocrinol (Lausanne); 2015; 6():96. PubMed ID: 26106367
[TBL] [Abstract][Full Text] [Related]
2. Genetics of tumors of the adrenal cortex.
Bonnet-Serrano F; Bertherat J
Endocr Relat Cancer; 2018 Mar; 25(3):R131-R152. PubMed ID: 29233839
[TBL] [Abstract][Full Text] [Related]
3. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
4. The genetics of adrenocortical tumors.
Espiard S; Bertherat J
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
[TBL] [Abstract][Full Text] [Related]
5. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
6. ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
Yu L; Zhang J; Guo X; Chen X; He Z; He Q
PLoS One; 2018; 13(1):e0191602. PubMed ID: 29370219
[TBL] [Abstract][Full Text] [Related]
7. Update of Genetic and Molecular Causes of Adrenocortical Hyperplasias Causing Cushing Syndrome.
Berthon A; Bertherat J
Horm Metab Res; 2020 Aug; 52(8):598-606. PubMed ID: 32097969
[TBL] [Abstract][Full Text] [Related]
8. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations.
Tang P; Zhang J; Peng S; Yan X; Wang Y; Wang S; Zhang Y; Liu G; Xu J; Huang Y; Zhang D; Liu Q; Jiang J; Lan W
BMC Endocr Disord; 2023 Apr; 23(1):77. PubMed ID: 37029354
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical tumorigenesis: Lessons from genetics.
Kamilaris CDC; Hannah-Shmouni F; Stratakis CA
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101428. PubMed ID: 32507359
[TBL] [Abstract][Full Text] [Related]
10. Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.
Ronchi CL; Di Dalmazi G; Faillot S; Sbiera S; Assié G; Weigand I; Calebiro D; Schwarzmayr T; Appenzeller S; Rubin B; Waldmann J; Scaroni C; Bartsch DK; Mantero F; Mannelli M; Kastelan D; Chiodini I; Bertherat J; Reincke M; Strom TM; Fassnacht M; Beuschlein F;
J Clin Endocrinol Metab; 2016 Sep; 101(9):3526-38. PubMed ID: 27389594
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of PRKACA mutations in Chinese patients with adrenal lesions: a single-centre study.
Li X; Wang B; Tang L; Lang B; Zhang Y; Zhang F; Chen L; Ouyang J; Zhang X
Clin Endocrinol (Oxf); 2016 Dec; 85(6):954-961. PubMed ID: 27296931
[TBL] [Abstract][Full Text] [Related]
12. The Many Faces of Primary Aldosteronism and Cushing Syndrome: A Reflection of Adrenocortical Tumor Heterogeneity.
Mete O; Duan K
Front Med (Lausanne); 2018; 5():54. PubMed ID: 29594118
[TBL] [Abstract][Full Text] [Related]
13. 5th International ACC Symposium: The New Genetics of Benign Adrenocortical Neoplasia: Hyperplasias, Adenomas, and Their Implications for Progression into Cancer.
Kirschner LS; Stratakis CA
Horm Cancer; 2016 Feb; 7(1):9-16. PubMed ID: 26684645
[TBL] [Abstract][Full Text] [Related]
14. A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.
Albiger NM; Regazzo D; Rubin B; Ferrara AM; Rizzati S; Taschin E; Ceccato F; Arnaldi G; Pecori Giraldi F; Stigliano A; Cerquetti L; Grimaldi F; De Menis E; Boscaro M; Iacobone M; Occhi G; Scaroni C
Endocrine; 2017 Mar; 55(3):959-968. PubMed ID: 27094308
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
[TBL] [Abstract][Full Text] [Related]
16. Extensive ARMC5 genetic variance in primary bilateral macronodular adrenal hyperplasia that started with exophthalmos: a case report.
Jin P; Janjua MU; Zhang Q; Dong CS; Yang Y; Mo ZH
J Med Case Rep; 2018 Jan; 12(1):13. PubMed ID: 29343284
[TBL] [Abstract][Full Text] [Related]
17. Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome.
Vaduva P; Bonnet F; Bertherat J
J Endocr Soc; 2020 Sep; 4(9):bvaa075. PubMed ID: 32783015
[TBL] [Abstract][Full Text] [Related]
18. A genetic and molecular update on adrenocortical causes of Cushing syndrome.
Lodish M; Stratakis CA
Nat Rev Endocrinol; 2016 May; 12(5):255-62. PubMed ID: 26965378
[TBL] [Abstract][Full Text] [Related]
19. New pathogenic variants in ARMC5 gene in a series of Italian patients affected by primary bilateral macronodular adrenocortical hyperplasia (PBMAH).
Giacché M; Panarotto A; Mori L; Poliani PL; Lanzi R; Lena MS; Castellano M
Mol Genet Genomic Med; 2023 Apr; 11(4):e2126. PubMed ID: 36727580
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of
Stratakis CA; Berthon A
Curr Opin Endocr Metab Res; 2019 Oct; 8():104-111. PubMed ID: 32864505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]